Cryptocurrency & Digital Assets

Linkhome's new AI promises to streamline home buying, but its debut raises questions about market disruption, ethics, and the future of real estate.

Manic Panic's new Inter-Gel-Actic collection features a revolutionary gel formula designed to make vibrant, at-home hair color easier than ever before.

With a key gas deal signed, construction begins on the world's largest ultra-low carbon methanol plant in Sinaloa, a $3.3B bet on sustainable fuels.

With no approved nonsurgical options for plantar fibromatosis, Keenova's new study and late-stage trial offer a significant glimmer of hope for sufferers.

With its expansion to Europe and LATAM, Halper AI and its founder are betting on a radical idea: the best AI is the one you never have to open.

Innovia Consulting acquires 365Vertical and 365 Cannabis, a strategic move to dominate specialized ERP markets like cannabis and agriculture.

A SPAC merger aims to list a key rare earths player on Nasdaq, fueling Europe's quest for mineral independence from China. Here is what's at stake.

MCF Energy's Welchau-1 well in Austria shows promising gas flows, a potential boost for regional energy independence amid ongoing geopolitical pressures.

The global market for smart gates is set to surge, driven by AI, biometrics, and security fears. But can we balance safety with personal privacy?

Three top Marriott resorts in Phuket & Khao Lak are wooing families with a new 'Kids Eat Free' program, promising big savings and diverse holiday experiences.

LEX Diagnostics' newly FDA-cleared VELO system delivers lab-quality PCR results for flu & COVID in under 10 minutes, set to revolutionize point-of-care testing.

Dr. Batra's launches XODerma, a high-tech exosome skin therapy in Dubai, blending homeopathy with cellular science. But does the hype outpace regulation?

The global energy giant unveils a new strategic roadmap and lubricants in India, betting on its distributor network to navigate a competitive, evolving market.

Indian startup DUSQ lands ₹24 crore to challenge global sleep-tech giants with a novel platform that promises to restore sleep, not just score it.

A landmark trial for Roche’s Gazyva shows unprecedented success in treating primary membranous nephropathy, offering hope of preventing kidney failure.

A new House Farm Bill threatens to overturn state animal welfare laws, weaken puppy mill protections, and ignore horse slaughter, sparking a major backlash.

Safe Bulkers sells a 14-year-old ship for $35.2M, capitalizing on a strong market to fund a new generation of eco-friendly vessels.

CenterWell's major acquisition of MaxHealth adds 82 clinics and 120,000 patients, deepening its hold on Florida's value-based senior care sector.

A new report reveals a nearly 6% drop in US beer shipments for 2025, signaling a major shift as consumers turn to spirits, cannabis, and NA options.

A new $500M fund aims to profit from the U.S. housing shortage by banking on its scarcest resource: land. But can it deliver for investors and builders?